Skip to Content

W 447 (Ranitidine hydrochloride 150 mg)

Pill imprint W 447 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 150 mg W 447
Ranitidine hydrochloride
W 447
150 mg
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Wockhardt Limited

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.